In vivo therapy monitoring of experimental rheumatoid arthritis in rats using near-infrared fluorescence imaging

• Published in: Journal of biomedical optics Vol. 19; no. 3
• Main Authors: Vollmer, Sonja, Gemeinhardt, Ines, Vater, Axel, Schnorr, Beatrix, Schnorr, Jorg, Voigt, Jan, Ebert, Bernd
• Format: Journal Article
• Language: English
• Published: 01.03.2014
• Subjects: Arthritis; Biomedical materials; Fluorescence; Imaging; In vivo testing; In vivo tests; Surgical implants; Therapy
• ISSN: 1083-3668; 1560-2281
• DOI: 10.1117/1.JBO.19.3.036010

An in vivo near-infrared fluorescence (NIRF) imaging technique is described for therapy monitoring of ankle joints affected by collagen-induced arthritis, a model of human rheumatoid arthritis. Arthritis was induced in rats by intradermal injections of collagen and Freund's incomplete adjuvant. For in vivo imaging, the nonspecific NIR dye tetrasulfocyanine (TSC) was used. Prior to and after treatment with a nonsteroidal anti-inflammatory drug, meloxicam, or analgesic drug, tramadol hydrochloride (which served as no-therapy control), normalized fluorescence intensities of each ankle joint were measured. Additionally, each ankle joint was characterized by clinical arthritis scoring and histopathology. Over a 3-week treatment period, a significant difference in disease progression between animals treated with meloxicam and tramadol hydrochloride was detected. A statistically significant improvement in ankle joint pathology from high- or moderate-grade to moderate- or low-grade upon meloxicam therapy, as determined by clinical evaluation, translated into a significant decrease in fluorescence intensity. In contrast, all arthritic joints of the no-therapy control group deteriorated to high-grade arthritis with high-fluorescence intensities in NIRF imaging.